NG
ALXN

NatWest Group’s Alexion Pharmaceuticals ALXN Stock Holding History

NatWest Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-4,657
Closed -$728K – 366
2015
Q3 		$728K Buy
+4,657
New +$849K 0.02% 225
2015
Q2 		– Sell
-4,725
Closed -$819K – 442
2015
Q1 		$819K Buy
4,725
+1,057
+29% +$191K 0.01% 248
2014
Q4 		$679 Buy
3,668
+366
+11% +$67.8K 0.01% 266
2014
Q3 		$547 Buy
+3,302
New +$542K ﹤0.01% 337
2014
Q1 		– Sell
-18,099
Closed -$2.4M – 720
2013
Q4 		$2.4M Buy
18,099
+3,456
+24% +$415K 0.06% 250
2013
Q3 		$1.7M Sell
14,643
-6,699
-31% -$735K 0.05% 289
2013
Q2 		$1.97M Buy
+21,342
New +$2.06M 0.04% 331

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return